Is Brilinta The Treatment To Keep AstraZeneca’s Lifeblood Flowing?

The company outlined plans to jumpstart growth of the anti-platelet drug Brilinta, including a 100% increase in marketing investment, increased rebates for payers and the addition of 200 nurse educators who will focus on the hospital discharge space.